This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Abbott Cardiovascular Systems, Inc.. Active years: 2012.
Company Filing History:
Years Active: 2012
Title: **Dan Joel Dirilo: Innovator in Electropolishing Technology**
Introduction
Dan Joel Dirilo, an inventive mind based in Union City, California, has made significant strides in the field of electropolishing with his innovative patent. His work is instrumental in advancing processes that enhance the quality and surface finishes of metal devices.
Latest Patents
Dirilo holds a patent for an **Automated Electropolishing Process**. This invention features a unique electropolishing system that includes an anode, a cathode, a rolling block, and a motion controller. The anode is designed to securely hold a metal device during the electropolishing process, efficiently transferring electricity to the device while simultaneously grooming its surface as it rolls against the block. The cathode, fashioned as a mesh, completes the electrical circuit, ensuring effective electropolishing. The innovation is complemented by a motion controller that allows for precise vertical and horizontal movements of the anode and metal device, adapting the force applied for optimal results.
Career Highlights
Dan is currently employed at Abbott Cardiovascular Systems, Inc., where he continues to push the boundaries of technology in his field. His role involves leveraging his expertise to contribute to advancements in cardiovascular solutions, underscoring his commitment to innovation.
Collaborations
Throughout his career, Dirilo has collaborated with notable coworkers, including Anthony S. Andreacchi and Andreina P. Gomez. These collaborations highlight the importance of teamwork in fostering advancements in technologies and processes in the medical field.
Conclusion
Dan Joel Dirilo stands out as a pioneering inventor in electropolishing technology. His patent not only exemplifies his innovative spirit but also contributes to the ongoing evolution of metal treatment processes in the industry. As he continues his work at Abbott Cardiovascular Systems, Inc., his impact on technology and medicine is sure to resonate for years to come.
